Hypertension, the Metabolic Syndrome, and the Risk of Developing Diabetes: Is It Time to Change the Guidelines?

This publication has 16 references indexed in Scilit:

• Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
  Hypertension, 2004
• A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
  JAMA, 2003
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report
  JAMA, 2003
• Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial
  JAMA, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
  The Lancet, 2000
• Relation of Low Body Mass to Death and Stroke in the Systolic Hypertension in the Elderly Program
  Archives of internal medicine (1960), 2000
• Role of Hypertension in Coronary Artery Disease
  American Journal of Nephrology, 1996
• Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan.
  Circulation, 1994
• Metabolic characteristics of hypertension: Importance of positive family history
  American Heart Journal, 1993